Novartis

India reserves right to act on drug patents after Novartis case

India reserves right to act on drug patents after Novartis case

Reuters

Can Bristol-Myers Squibb Compete In Immuno-Oncology?

Can Bristol-Myers Squibb Compete In Immuno-Oncology?

Seeking Alpha

A Critical Analysis Of Pfizer's Pipeline, Earnings And Valuation

A Critical Analysis Of Pfizer's Pipeline, Earnings And Valuation

Seeking Alpha

Can New Psoriasis Drugs Scratch Investors' Itch?

Can New Psoriasis Drugs Scratch Investors' Itch?

Investors.com

Evolution Of Biotech Industry: A Quick Look At Diversification, Divesting And Partnering

Evolution Of Biotech Industry: A Quick Look At Diversification, Divesting And Partnering

Seeking Alpha

Pfizer, Novartis, Abbott weigh bids for Brazil's Ache - sources

Pfizer, Novartis, Abbott weigh bids for Brazil's Ache - sources

Reuters

Zalicus: Renewing Partnership With Novartis Will Be Vital For 2013 Revenues

Zalicus: Renewing Partnership With Novartis Will Be Vital For 2013 Revenues

Seeking Alpha

U.S. trade office reviewing India's Supreme Court drug ruling

U.S. trade office reviewing India's Supreme Court drug ruling

Reuters

Will Novartis decision impact U.S. drug prices?

Will Novartis decision impact U.S. drug prices?

Marketwatch

Tecfidera Raises The Bar For Biogen Idec

Tecfidera Raises The Bar For Biogen Idec

Seeking Alpha